113 related articles for article (PubMed ID: 31591460)
1. CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma.
Tong L; Li J; Choi J; Pant A; Xia Y; Jackson C; Liu P; Yi L; Boussouf E; Lim M; Yang X
Cancer Gene Ther; 2020 Sep; 27(9):669-679. PubMed ID: 31591460
[TBL] [Abstract][Full Text] [Related]
2. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
Fan HW; Ni Q; Fan YN; Ma ZX; Li YB
Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619
[TBL] [Abstract][Full Text] [Related]
3. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.
Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434
[TBL] [Abstract][Full Text] [Related]
4. Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients.
Wang J; Tong L; Lin G; Wang H; Zhang L; Yang X
BMC Cancer; 2020 Sep; 20(1):931. PubMed ID: 32993564
[TBL] [Abstract][Full Text] [Related]
5. A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis.
Chen R; Wu W; Chen SY; Liu ZZ; Wen ZP; Yu J; Zhang LB; Liu Z; Zhang J; Luo P; Zeng WJ; Cheng Q
Front Immunol; 2022; 13():831542. PubMed ID: 35979347
[TBL] [Abstract][Full Text] [Related]
6. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.
Tong L; Li J; Li Q; Wang X; Medikonda R; Zhao T; Li T; Ma H; Yi L; Liu P; Xie Y; Choi J; Yu S; Lin Y; Dong J; Huang Q; Jin X; Lim M; Yang X
Theranostics; 2020; 10(13):5943-5956. PubMed ID: 32483429
[TBL] [Abstract][Full Text] [Related]
7. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
Zhang C; Li J; Wang H; Song SW
Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
9. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
[TBL] [Abstract][Full Text] [Related]
10. CLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis.
Huang YL; Chen ST; Liu RS; Chen YH; Lin CY; Huang CH; Shu PY; Liao CL; Hsieh SL
J Mol Med (Berl); 2016 Sep; 94(9):1025-37. PubMed ID: 27033255
[TBL] [Abstract][Full Text] [Related]
11. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
Lvu W; Fei X; Chen C; Zhang B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
[TBL] [Abstract][Full Text] [Related]
12. CLEC5A is critical for dengue-virus-induced lethal disease.
Chen ST; Lin YL; Huang MT; Wu MF; Cheng SC; Lei HY; Lee CK; Chiou TW; Wong CH; Hsieh SL
Nature; 2008 May; 453(7195):672-6. PubMed ID: 18496526
[TBL] [Abstract][Full Text] [Related]
13. Elevated Expression of C-Type Lectin Domain Family 5-Member A (CLEC5A) and Its Relation to Inflammatory Parameters and Disease Course in Adult-Onset Still's Disease.
Chen PK; Hsieh SL; Lan JL; Lin CC; Chang SH; Chen DY
J Immunol Res; 2020; 2020():9473497. PubMed ID: 32377540
[TBL] [Abstract][Full Text] [Related]
14. Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma.
Chen Q; Han B; Meng X; Duan C; Yang C; Wu Z; Magafurov D; Zhao S; Safin S; Jiang C; Cai J
Int J Cancer; 2019 Jul; 145(2):517-530. PubMed ID: 30613962
[TBL] [Abstract][Full Text] [Related]
15. Genetic association analysis of
Elleisy N; Rohde S; Huth A; Gittel N; Glass Ä; Möller S; Lamprecht G; Schäffler H; Jaster R
World J Gastroenterol; 2020 May; 26(18):2194-2202. PubMed ID: 32476786
[TBL] [Abstract][Full Text] [Related]
16. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
17. The macrophage C-type lectin receptor CLEC5A (MDL-1) expression is associated with early plaque progression and promotes macrophage survival.
Xiong W; Wang H; Lu L; Xi R; Wang F; Gu G; Tao R
J Transl Med; 2017 Nov; 15(1):234. PubMed ID: 29126450
[TBL] [Abstract][Full Text] [Related]
18. Association of rs1285933 single nucleotide polymorphism in CLEC5A gene with dengue severity and its functional effects.
Xavier-Carvalho C; Cezar RDDS; Freire NM; Vasconcelos CMM; Solorzano VEF; de Toledo-Pinto TG; Fialho LG; do Carmo RF; Vasconcelos LRS; Cordeiro MT; Baptista P; de Azeredo EL; da Cunha RV; de Souza LJ; Pacheco AG; Kubelka CF; Moura PMMF; Moraes MO
Hum Immunol; 2017 Oct; 78(10):649-656. PubMed ID: 28764923
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor CEBPB inhibits the proliferation of osteosarcoma by regulating downstream target gene CLEC5A.
Lu J; Chen W; Liu H; Yang H; Liu T
J Clin Lab Anal; 2019 Nov; 33(9):e22985. PubMed ID: 31364785
[TBL] [Abstract][Full Text] [Related]
20. Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.
Guo Q; Guan GF; Cheng W; Zou CY; Zhu C; Cheng P; Wu AH
CNS Neurosci Ther; 2019 Mar; 25(3):343-354. PubMed ID: 30311408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
